AIGIV (ANTHRASIL)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AIGIV (ANTHRASIL), covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax